Advanced search

Biodistribution and dosimetry of Tc-99m-depreotide (P829) in patients suffering from breast carcinoma

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Van Den Bossche, Bieke, E D’HAENINCK, Klaus Bacher, Hubert Thierens, Simon Van Belle, Rudi Dierckx, and Christophe Van De Wiele. 2004. “Biodistribution and Dosimetry of Tc-99m-depreotide (P829) in Patients Suffering from Breast Carcinoma.” Cancer Biotherapy and Radiopharmaceuticals 19 (6): 776–783.
APA
Van Den Bossche, Bieke, D’HAENINCK, E., Bacher, K., Thierens, H., Van Belle, S., Dierckx, R., & Van De Wiele, C. (2004). Biodistribution and dosimetry of Tc-99m-depreotide (P829) in patients suffering from breast carcinoma. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 19(6), 776–783.
Vancouver
1.
Van Den Bossche B, D’HAENINCK E, Bacher K, Thierens H, Van Belle S, Dierckx R, et al. Biodistribution and dosimetry of Tc-99m-depreotide (P829) in patients suffering from breast carcinoma. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. MARY ANN LIEBERT INC; 2004;19(6):776–83.
MLA
Van Den Bossche, Bieke, E D’HAENINCK, Klaus Bacher, et al. “Biodistribution and Dosimetry of Tc-99m-depreotide (P829) in Patients Suffering from Breast Carcinoma.” CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 19.6 (2004): 776–783. Print.
@article{303030,
  author       = {VAN DEN BOSSCHE, BIEKE and D'HAENINCK, E and Bacher, Klaus and Thierens, Hubert and Van Belle, Simon and Dierckx, Rudi and Van De Wiele, Christophe},
  issn         = {1084-9785},
  journal      = {CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS},
  language     = {eng},
  number       = {6},
  pages        = {776--783},
  publisher    = {MARY ANN LIEBERT INC},
  title        = {Biodistribution and dosimetry of Tc-99m-depreotide (P829) in patients suffering from breast carcinoma},
  volume       = {19},
  year         = {2004},
}

Web of Science
Times cited: